In addition, our study revealed that the incidence of CD133+, CD44+/CD133+, CD166+/CD133+ and CD133+/CD166+/CD44+ cells in OSCC, increased significantly with the increase in tumor invasion depth (p ≤ 0.05), implying the positive correlation. The gene discussed is PROM1; the disease is neoplasm.